Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC) episode artwork

EPISODE · Sep 30, 2024 · 18 MIN

Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)

from Conversations in Lung Cancer Research · host Associate Professor Zarnie Lwin, Zarnie Lwin, Associate Professor Susan Harden, Susan Harden, Dr. Wei-Sen Lam, wei-sen lam

Support TOGAThank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.---------------Connect with TOGAAttend an Event: https://thoraciconcology.org.au/events/Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/Follow UsLinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/X (Twitter): https://x.com/TOGAANZInstagram: https://www.instagram.com/togaanz/YouTube:  https://www.youtube.com/@Thoracic_Oncology---------------Acknowledgement of CountryThe Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Episode metadata supplied by the publisher feed · Published Sep 30, 2024

Embed this episode

In this episode, we dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining us are leading experts in oncology Zarnie Lwin, Susan Harden and Wei-Sen Lam. Together, they explore the significance of the ADRIATIC trial results, debate the role of prophylactic cranial irradiation (PCI) in the treatment of SCLC, and provide insights into ongoing studies that may further improve outcomes for patients. Tune in for a deep dive into the latest research and expert perspectives on this aggressive cancer. Podcasters: Associate Professor Zarnie Lwin, OAM, Medical Oncologist at Royal Brisbane Women’s Hospital and the University of Queensland, QLD Associate Professor Susan Harden, Radiation Oncologist at Peter MacCallum Cancer Centre and Monash Cancer Registries, VIC Dr. Wei-Sen Lam, Medical Oncologist and TeleHealth lead at Fiona Stanley and Esperance Hospitals, WA

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)

0:00 18:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Conversations in Lung Cancer Research?

This episode is 18 minutes long.

When was this Conversations in Lung Cancer Research episode published?

This episode was published on September 30, 2024.

Can I download this Conversations in Lung Cancer Research episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!